Login
← Go Back
Themis Medicare
THEMISMED · Pharma > Pharmaceuticals & Drugs · Chairman: Hoshang N Sinor · MD: Sachin D Patel · Listing date: April 2, 2007 · Employees: 976 · Mumbai · http://www.themismedicare.com
Stock Price vs Company Growth
1d
5.8%
1w
7.3%
1m
19.2%
3m
10.1%
6m
10.8%
1y
19.4%
5y
1.5%
10y
5.2%
all
11.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 100 5.8%
99.3
140
Company Overview
Sales
332 Cr
Growth: -6.8%
Profit after Tax
-53 Cr
Growth: -4735.1%
Small Cap
925 Cr
P/E: 23.2x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 332
Growth -6.8%
EBITDA -12.6%
P/S 2.8x
Dividend 0.5%
P/E 23.2x
Book Value ₹ 32.3
PEG Ratio -3.6x
ROE -15.4%
P/B 3.3x
Shareholding Pattern
Institutions
Anuj Anantrai Sheth
4.89 %
Zafar Ahmadullah
1.76 %
Za Capital Services India Private Ltd
1.29 %
Iepf
0.34 %
Promoters
Vividhmargi Investments Private Ltd.
15.8 %
Gedeon Richter Investment Management Ltd.
9.62 %
Dinesh Shantilal Patel
9.49 %
Vividh Distributors Private Ltd.
7.79 %
Jayshree D Patel
7.26 %
Others
Increase    Decrease    No change
Company Profile Detailed
Themis Medicare (TML) incorporated in 1969, is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. Erstwhile known as Themis Chemical the company is promoted by Mr. Shantibhai D. Patel. It is joint venture with Gedeon Richter, Hungary.Headquartered in Mumbai, the company has four manufacturing facilities located at Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar (Uttaranchal).
Belongs to (4 Indices)
Investors (51)
zafar.ah...
avantika...
iifl.sec...
Followers (2)
vinodgow...
tejasdod...